End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 THB | +1.46% |
|
+4.51% | -2.42% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's enterprise value to sales, at 3.3 times its current sales, is high.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.42% | 15Cr | - | ||
-32.87% | 1.36TCr | B+ | ||
+4.15% | 1.18TCr | B+ | ||
-3.60% | 1.15TCr | B | ||
+8.65% | 1.08TCr | B+ | ||
+27.20% | 859.42Cr | B | ||
-11.67% | 728.69Cr | A- | ||
+7.99% | 685.32Cr | B- | ||
+9.12% | 640.79Cr | D | ||
+15.57% | 438.76Cr | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EKH Stock
- Ratings Ekachai Medical Care